Long-term outcome of Hurler syndrome following bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  American journal of medical genetics

• Publication date

  1993-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/AJMG.1320460222PMID 8484412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computed tomography studies on patients with mucopolysaccharidoses

  2004cited by this paper
• Mucopolysaccharidosis type I (Hurler syndrome): Linkage disequilibrium indicates the presence of a major allele

  1992cited by this paper
• Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation.

  1992cited by this paper
• PCR of a Kpnl RFLP in the a-L-iduronidase (IDUA) gene

  1991cited by this paper
• Bone marrow transplantation for genetic diseases.

  1991cited by this paper
• Human alpha-L-iduronidase: cDNA isolation and expression.

  1991cited by this paper
• PCR of a KpnI RFLP in the alpha-L-iduronidase (IDUA) gene.

  1991cited by this paper
• Busulfan disposition in children.

  1990cited by this paper
• Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation.

  1990cited by this paper
• Bone marrow transplantation for genetic diseases.

  1990cited by this paper
• Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report.

  1989cited by this paper
• Diagnostic test for mucopolysaccharidosis. II. Rapid quantification of glycosaminoglycan in urine samples collected on a paper matrix.

  1989cited by this paper
• Radiographic findings in a canine model of mucopolysaccharidosis I. Changes associated with bone marrow transplantation.

  1988cited by this paper
• Long-Term Neurological Effects of Bone Marrow Transplantation in a Canine Lysosomal Storage Disease

  1988cited by this paper
• Outcome of Displacement Bone Marrow Transplantation for Inborn Errors of Metabolism

  1988cited by this paper
• Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplantation.

  1988cited by this paper
• Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.

  1987cited by this paper
• A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome.

  1987cited by this paper
• Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation.

  1987cited by this paper
• Experience with bone marrow transplantation for inborn errors of metabolism.

  1987cited by this paper
• Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction.

  1986cited by this paper
• The application of bone marrow transplantation to the treatment of genetic diseases.

  1986cited by this paper
• Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation.

  1985cited by this paper
• The clinical spectrum of alpha-L-iduronidase deficiency.

  1985cited by this paper
• The clinical spectrum of a-L-iduronidase deficiency

  1985cited by this paper
• Magnetic resonance imaging of the brain in Hurler syndrome.

  1984cited by this paper
• Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.

  1984cited by this paper
• Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.

  1983cited by this paper
• A randomized study of the prevention of acute graft-versus-host disease.

  1982cited by this paper
• Bone marrow transplantation for inborn errors.

  1981cited by this paper
• Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation.

  1981cited by this paper
• Spastic quadriparesis due to C1-C2 subluxation in Hurler syndrome.

  1978cited by this paper
• ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION

  1975cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• Measurement of Urinary Glycosaminoglycans with Quaternary Ammonium Salts : An Extension of the Method

  1972cited by this paper

• Beyond Detection: Comparing State-Based Newborn Screening Methods for Effective Mucopolysaccharidosis I Diagnosis

  2026cites this paper
• Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series

  2025cites this paper
• Effect of Early Hematopoietic Stem Cell Transplantation on Carpal Tunnel Syndrome Surgery in Patients With Hurler Syndrome.

  2025cites this paper
• Umbilical Cord Blood Transplantation in Lesch-Nyhan Syndrome: A Case Report and Literature Review

  2025cites this paper
• Entering the playing field: Therapy for multiple sulfatase deficiency.

  2024cites this paper
• Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system

  2022cites this paper
• Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review

  2022cites this paper
• Mucopolysaccharidoses

  2021cites this paper
• Aspects of Surgical Treatment of Spinal Pathology in the Patient with Gurler Syndrome

  2021influential citation
• Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

  2021cites this paper
• Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation

  2021cites this paper
• The natural history of neurocognition in MPS disorders: A review.

  2021cites this paper
• Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I

  2020cites this paper
• Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10

  2020cites this paper
• Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

  2020cites this paper
• Step-up approach for surgical treatment of the spinal canal stenosis in a patient with mucopolysaccharidosis type VI (Maroto–Lami syndrome)

  2020cites this paper
• Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I.

  2020cites this paper
• HURLER SYNDROME: A MINI REVIEW

  2019cites this paper
• The Hip in Mucopolysaccharidoses

  2019cites this paper
• The hematopoietic stem cell transplantation in children with Hurler syndrome

  2019cites this paper
• Вертебральный синдром при различных типах мукополисахаридоза: особенности клиники и лечения

  2019cites this paper
• The vertebral syndrome in various types of mucopolysaccharidosis: clinical features and treatment

  2019cites this paper
• Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

  2019cites this paper
• Improving diagnosis and treatment outcomes in mucopolysaccharidoses

  2019cites this paper
• P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.

  2018cites this paper
• JIMD Reports, Volume 41: Focus Issue: Adults and Metabolism

  2018cites this paper
• Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses.

  2017cites this paper
• Surgical management of neurological manifestations of mucopolysaccharidosis disorders.

  2017cites this paper
• Treatment of brain disease in the mucopolysaccharidoses.

  2017cites this paper
• Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease

  2017cites this paper
• New in Newborn Screening

  2017cites this paper
• Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation

  2017cites this paper
• Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I

  2017cites this paper
• Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis

  2017cites this paper
• Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms.

  2017cites this paper
• Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure.

  2017cites this paper
• Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System–Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer

  2017cites this paper
• Mucopolysaccharidosis I (MPS I)

  2017cites this paper
• Pre-transplant ferritin , albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation

  2017cites this paper
• Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature.

  2017cites this paper
• 74. Hematopoietic Cell Transplantation for Storage Diseases

  2016cites this paper
• The Different Forms of Mucopolysaccharidosis with Neurological Involvement: A Case-Based Review

  2016cites this paper
• Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I

  2016cites this paper
• Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases

  2016cites this paper
• Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model.

  2016cites this paper
• Activity of daily living for Morquio A syndrome.

  2016cites this paper
• Hematopoietic stem cell transplant for the mucopolysaccharidoses

  2016cites this paper
• AAV Gene Therapy for MPS1-associated Corneal Blindness

  2016cites this paper
• Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.

  2015cites this paper
• Molecular Therapy and Gene Therapy for Hurler Syndrome A THESIS SUBMITTED TO THE FACULTY OF UNIVERSITY OF MINNESOTA BY Li Ou IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY

  2015cites this paper
• Improving the diagnosis and treatment of MPS I

  2015cites this paper
• Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.

  2015cites this paper
• Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.

  2015cites this paper
• Diagnosis, classification and treatment of mucopolysaccharidosis type I

  2015cites this paper
• Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.

  2015cites this paper
• Gene therapy for neurologic manifestations of mucopolysaccharidoses

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Improving the diagnosis and treatment of MPS

  2015cites this paper
• Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I

  2014influential citation
• Early treatment is associated with improved cognition in Hurler syndrome

  2014cites this paper
• Current and potential therapeutic strategies for mucopolysaccharidoses

  2014cites this paper
• Current and emerging management options for patients with Morquio A syndrome

  2013cites this paper
• Stem Cell Therapy in Lysosomal Storage Diseases

  2013cites this paper
• Leukodystrophies and Lysosomal Storage Disorders

  2013cites this paper
• Hip Dysplasia in Patients With Hurler Syndrome (Mucopolysaccharidosis Type 1H)

  2013cites this paper
• Management of mucopolysaccharidosis type IH (Hurler’s syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution’s experience

  2013influential citation
• Current and emerging management options for patients with Morquio A syndrome

  2013cites this paper
• Treatment of Lysosomal Storage Disorders

  2012cites this paper
• Delivering drugs to the central nervous system: an overview

  2012cites this paper
• Exploring hurler syndrome through the study of disease-specific multipotent and pluripotent stem cells

  2012cites this paper
• Corneal hysteresis in mucopolysaccharidosis I and VI

  2012cites this paper
• Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I‐Hurler)

  2012cites this paper
• Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion.

  2011cites this paper
• Autologous Transplantation of Lentivector/Acid Ceramidase–Transduced Hematopoietic Cells in Nonhuman Primates

  2011cites this paper
• Research challenges in central nervous system manifestations of inborn errors of metabolism.

  2011cites this paper
• Mukopolisacharydozy — biochemiczne mechanizmy chorób oraz możliwości terapeutyczne

  2011cites this paper
• Increased Longevity and Metabolic Correction Following Syngeneic Bone Marrow Transplantation in a Murine Model of Mucopolysaccharidosis Type I

  2011cites this paper
• Gene therapy for lysosomal storage disorders

  2011cites this paper
• Umbilical cord blood banking: an update

  2011cites this paper
• Intrathecal enzyme replacement therapy for mucopolysaccharidosis I: translating success in animal models to patients.

  2011cites this paper
• Hematopoietic stem cell transplantation for metabolic storage diseases

  2010cites this paper
• Replacing the Enzyme α-l-Iduronidase at Birth Ameliorates Symptoms in the Brain and Periphery of Dogs with Mucopolysaccharidosis Type I

  2010cites this paper
• Neuro-Ophthalmologic Manifestations of Neurodegenerative Disease in Childhood

  2010cites this paper
• Transplant outcomes in mucopolysaccharidoses.

  2010cites this paper
• Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions

  2010cites this paper
• ESTABELECIMENTO DE UM NOVO MÉTODO DE DIAGNÓSTICO MOLECULAR PARA MUCOPOLISSACARIDOSE TIPO I

  2010cites this paper
• Clinical Outcome of Cerebrospinal Fluid Shunting for Communicating Hydrocephalus in Mucopolysaccharidoses I, II, and III: A Retrospective Analysis of 13 Patients

  2010cites this paper
• Molecular Therapy for Mucopolysaccharidosis Type I

  2010cites this paper
• Mucopolysaccharidosis I: Management and Treatment Guidelines

  2009cites this paper
• Enzyme replacement therapy treatment from birth increases therapeutic effic acy and generates tolerance to enzyme in canine mucopolysaccharidosis type I

  2009influential citation
• Psychosocial outcomes of bone marrow transplant for individuals affected by MPS I Hurler Disease

  2009cites this paper
• Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005

  2009cites this paper
• Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.

  2009cites this paper
• 12. Suppression of a nonsense mutation in a mouse model of Hurler syndrome

  2009cites this paper
• Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome

  2008cites this paper
• Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.

  2008cites this paper
• The mucopolysaccharidoses: a success of molecular medicine

  2008cites this paper
• Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

  2008cites this paper
• Central nervous system therapy for lysosomal storage disorders.

  2008cites this paper
• The clinical outcome of Hurler syndrome after stem cell transplantation.

  2008cites this paper
• Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidoses

  2007cites this paper